Replies to post #41349 on Easton Pharmaceuticals, Inc. (EAPH)

[Aggie14]

You hit the nail on the head. Some people can't let go of the past. EAPH is now with the big dogs. GLTU.

[Dan321]

My money is in the present and that's what I am looking at. Right now the MACD is telling me we are at a tipping point. This would be a great time for news. Plenty of room for another run now, after recent consolidation. But what do I know? I can't predict the future! Lol

[mckinley1]

EAPH in a strong position entering 2017 with Major Pharmaceutical Companies bidding for Exclusive Sales, Marketing, and Distribution of Approved Women's Health Products for Mexico and Latin America from EAPH.
Many exciting contracts in the works and to be announced.

The agreement with Gedeon Richter Mexico S.A.P.I . de C.V. for "Gynofit" is separate from Easton / BMV's other patented and exclusive diagnostic products (VagiSan (VS-Sense) & AmnioSense (AL-Sense) for which Easton is currently in separate late stage negotiations with large multi-national pharmaceutical companies.

In other developments, Easton Pharmaceuticals has entered into and are in late stage negotiations with BMV Medica SA de C.V. to acquire all of BMV and its assets. In addition, Easton is in late stage negotiations for an international medical marijuana initiative and to acquire a profitable and steadily growing Vaporizer company with their own line of manufactured and proprietary e-liquids and accessories, possessing growing international sales. News updates to be made available as they develop.